Given that SOCE via STIM1 promotes responses of FcεRI (29) and MRGPRX2, two important mast cells receptors that mediate allergy in humans; future studies designed to characterize this mechanism further may lead to the development of novel therapeutic approaches for the treatment of allergic diseases. The gene discussed is MRGPRX2; the disease is allergic disease.